CBIS Pulse is faint but pulsing with research quivers...Watch CCI momentum with MACD here. . . future profits and earnings TBD. Await patents and studies. Expect they'll eventually have to sell the farm here to pay for all the cannabis / hemp studies. Ent Value / Mkt Value is 1.02. A new medical advisory board for new medical products. One patent issued 2017 for treatment of neurobahaviors and could lead to positive litigation...TBD. This is a watch and wait scenerio for entry...@pokethebear
Studies mainly on Endogenous cannabinnoid family, which are produced in our bodies, vs natural occuring phytocannabinoids from cannabis, or made synthetically. CBIS studies may be specific to proving scientific value as neuromodulators and their absorption/binding to the our bodies fatty lipid areas/tissues and possibly dosage. If there's a pHD in the room to help confirm wording here, but the study and health benefits of CBD, CBDA, CBG, CBGA, THC, THCA, 9-THC, 9-THCA, 8-THC and THCV. Aka proving the science to the F&DA each endocannabinoid does something specific (sleep aid, pain releif, epileptic med., ADHD/ADD med., reduce inflamation, anxiety, psoriasis (skin inflammation), slows bacterial growth, inhibit cancer cells (first study published), stimulate appetite, reduce vomiting/diarrhea, and several other benefits.
